Oral butylphthalide capsules for preventing migraine attacks
Part of Brain & nervous system clinical trials.
This trial tests whether an oral capsule called butylphthalide (also known as NBP) can help prevent migraine attacks in adults who get them regularly. If you have migraines 4–14 days per month, this study may offer a new preventive option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had migraines (with or without aura) for at least 1 year.
- Your migraines started before age 50.
- You have 4 to 14 migraine days per month.
- You can tell the difference between migraines and other headaches.
- You are willing to use birth control during the study (if you are of childbearing age or have a partner who is).
- You do not have certain health conditions, like severe heart problems or a history of certain surgeries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication called NB001 for treating migraine attacks as they happen. If you have frequent migraines, this treatment might help reduce the severity or shorten the duration of your attacks.
This trial compares two different first-time preventive treatments for migraine in a primary care setting. If you qualify, you'll receive one of the study medications, and the research team will track how well it reduces your migraine days.
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
This trial tests if a gentle nasal stimulation device can help prevent migraines. It is for adults with frequent migraines (at least 8 days per month).
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This study tests an oral medication called atogepant to prevent migraines in adults in the UK. It aims to see how well it works when prescribed by a general practitioner in primary care.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.